Little Chesterford, United Kingdom

Philip Jackson

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Medivir Ab. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Philip Jackson. Retrieved from https://idiyas.com/inventor/philip-jackson-mbrz5azd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Profile: Philip Jackson

Introduction

Philip Jackson, an accomplished inventor based in Little Chesterford, GB, has made significant contributions to the field of biochemistry. Known for his work on cysteine protease inhibitors, his innovations have the potential to impact various therapeutic applications.

Latest Patents

Jackson holds one patent focusing on a compound related to cysteine protease inhibitors. This development underscores his commitment to advancing medical science and exploring new avenues for treatment.

Career Highlights

Philip Jackson's career is highlighted by his role at Medivir AB, a company dedicated to pioneering antiviral therapies. His expertise in biochemistry and innovation has positioned him as a key contributor within this dynamic field.

Collaborations

Throughout his career, Jackson has collaborated with notable scientists, including Magnus Nilsson and Xiao-Xiong Zhou. These partnerships reflect a collaborative spirit that fosters innovation and the sharing of knowledge essential for advancing research endeavors.

Conclusion

Philip Jackson is a distinguished inventor whose work in cysteine protease inhibitors showcases his dedication to scientific advancement. His collaboration with Medivir AB and esteemed colleagues demonstrates a strong commitment to developing innovative solutions within the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…